Search | IOVS | ARVO Journals

Showing 1 – 20 of 50

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

Retina July 2024

Differential Expression of Sex-Steroid Receptors in the Choroid Aligns With Central Serous Chorioretinopathy Sex Prevalence Across Different Ages

PDF

Sekar Galuh; Onno C. Meijer; Joost Brinks; Reinier O. Schlingemann; Camiel J. F. Boon; Robert M. Verdijk; Elon H. C. van Dijk
TAGS: central serous chorioretinopathy, choroid, gonadal steroid hormones, prevalence, electroconvulsive therapy, epidural cortical stimulation, stromal cells, premenopause
Invest. Ophthalmol. Vis. Sci.. 2024; 65(8):5. https://doi.org/10.1167/iovs.65.8.5

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2024

Correlation of Aqueous and Vitreous Protein Levels in Proliferative Diabetic Retinopathy and Their Association with Clinical Parameters

Ingeborg Klaassen; Reinier O. Schlingemann; David H. W. Steel

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):855.

ARVO Annual Meeting Abstract June 2024

Shared pathophysiology in the neurovascular unit of the human retina and Alzheimer’s brain in type 2 diabetes

Noëlle Bakker; Cornelis J.F. van Noorden; Reinier O. Schlingemann; Ingeborg Klaassen

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):333.

ARVO Annual Meeting Abstract June 2024

Identifying PLVAP-associated proteins involved in breakdown of the blood-retinal barrier in DME

Mathilda van Breest Smallenburg; Reinier O. Schlingemann; Cornelis J.F. van Noorden; Ingeborg Klaassen

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):319.

ARVO Annual Meeting Abstract June 2024

Choroidal hyperpermeability patterns correlate with disease severity in central serous chorioretinopathy: CERTAIN study report 2.

Laurenz J. B. Pauleikhoff; Roselie M. H. Diederen; Jennifer M. Chang-Wolf; Annette C. Moll; Reinier O. Schlingemann; Elon H. C. van Dijk; Camiel J. F. Boon

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):1727.

ARVO Annual Meeting Abstract June 2024

Immunolocalization of sex-steroid receptors in the human eye tissue across ages: an implication for pregnancy-associated central serous chorioretinopathy

Sekar Galuh; Onno Meijer; Joost Brinks; Reinier O. Schlingemann; Camiel Boon; Rob Verdijk; Elon H. C. van Dijk

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):1281.

ARVO Annual Meeting Abstract June 2024

iPSC-derived blood vessel organoids to study pathological angiogenesis in ocular neovascular diseases

Paola Serrano Martinez; Maxime Cammeraat; Lugmaan Ibrahim; Cornelis J.F. van Noorden; Reinier O. Schlingemann; Ingeborg Klaassen

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):4540.

ARVO Annual Meeting Abstract June 2023

Cortisol-modulated Barrier Properties of Cultured Choroidal Endothelial Cells: a Model to Study Central Serous Chorioretinopathy

Sekar Galuh; Elon van Dijk; Esmeralda K. Bosma; Joost Brinks; Reinier O. Schlingemann; Ingeborg Klaassen; Onno C. Meijer; Camiel J.F. Boon

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3008.

ARVO Annual Meeting Abstract June 2022

Safety and efficacy of fovea-involving half-dose photodynamic therapy for chronic central serous chorioretinopathy

Helena Margaret Anthonia Feenstra; Roselie M.H. Diederen; Martine J.C.M. Lamme; Sascha Fauser; Susan M. Downes; Reinier O. Schlingemann; Carel C B Hoyng; Elon H.C. van Dijk; Camiel J F Boon

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):37.

ARVO Annual Meeting Abstract June 2022

Spontaneous resolution of subretinal fluid in chronic central serous chorioretinopathy: the Fuji sign

Camiel J F Boon; Helena Margaret Anthonia Feenstra; Jonathan Hensman; Theodora Gkika; Carel C B Hoyng; Roselie M.H. Diederen; Reinier O. Schlingemann; Susan M. Downes; Elon H.C. van Dijk

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3763 – F0184.

ARVO Annual Meeting Abstract June 2020

MicroRNA levels as a biomarker for anti-VEGF response in patients with diabetic macular edema

Maartje J.C. Vader; Reinier O. Schlingemann; Ingeborg Klaassen

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):4355.

Articles May 2020

microRNA Expression Profile in the Vitreous of Proliferative Diabetic Retinopathy Patients and Differences from Patients Treated with Anti-VEGF Therapy

PDF

Julian Friedrich; David H. W. Steel; Reinier O. Schlingemann; Michael J. Koss; Hans-Peter Hammes; Guido Krenning; Ingeborg Klaassen
TAGS: micrornas, vitreous body, anti-vascular endothelial growth factor therapy
Trans. Vis. Sci. Tech.. 2020; 9(6):16. https://doi.org/10.1167/tvst.9.6.16

Includes: Supplemental Content

ARVO Annual Meeting Abstract July 2019

Comparing the efficacy of bevacizumab to ranibizumab in patients with diabetic macular edema: the BRDME study

Maartje J.C. Vader; Ann-Sofie M.E. Schauwvlieghe; Frank D Verbraak; Greetje Dijkman; Johanna M.M. Hooymans; Leonie I. Los; Aeilko H. Zwinderman; Tunde Peto; Carel B. Hoyng; Redmer van Leeuwen; Johannes R. Vingerling; Annette C. Moll; Janneke J.C. van Lith-Verhoeven; Marcel G.W. Dijkgraaf; Reinier O. Schlingemann

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3648.

ARVO Annual Meeting Abstract July 2018

Sodium iodate-induced retinal degeneration in small animal models for Age-related Macular degeneration

Céline Koster; Anneloor ten Asbroek; Jacoline ten Brink; Reinier O Schlingemann; Jan C van Meurs; Frank D Verbraak; Theo Smit; Camiel Boon; Arthur A Bergen

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):6062.

Retinal Cell Biology July 2017

TNFα-Induced Disruption of the Blood–Retinal Barrier In Vitro Is Regulated by Intracellular 3′,5′-Cyclic Adenosine Monophosphate Levels

PDF

Anne-Eva van der Wijk; Ilse M. C. Vogels; Cornelis J. F. van Noorden; Ingeborg Klaassen; Reinier O. Schlingemann
TAGS: cyclic amp, permeability, adenosine monophosphate, blood-retinal barrier
Invest. Ophthalmol. Vis. Sci.. 2017; 58(9):3496-3505. https://doi.org/10.1167/iovs.16-21091

Includes: Supplemental Content

Retina November 2016

Association of Circulating Markers With Outcome Parameters in the Bevacizumab and Ranibizumab in Diabetic Macular Edema Trial

PDF

Ward Fickweiler; Ingeborg Klaassen; Ilse M. C. Vogels; Johanna M. M. Hooymans; Bruce H. R. Wolffenbuttel; Leonoor I. Los; Reinier O. Schlingemann; for the BRDME Research Group
TAGS: bevacizumab, biological markers, diabetic macular edema, ranibizumab, rhodopsin, rna, messenger, visual acuity, plasma, anti-vascular endothelial growth factor therapy, eye
Invest. Ophthalmol. Vis. Sci.. 2016; 57(14):6234-6241. https://doi.org/10.1167/iovs.16-20157

ARVO Annual Meeting Abstract September 2016

Type 2 diabetes mellitus patients with white dots in the central fundus and neuroretinal degeneration

Stanley Darma; Reinier O. Schlingemann; Pauline Kok; Michael David Abramoff; Frits Holleman; Frank D Verbraak

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):4238.

Retina March 2016

HIV-Associated Neuroretinal Disorder in Patients With Well-Suppressed HIV-Infection: A Comparative Cohort Study

PDF

Nazli Demirkaya; Ferdinand W. N. M. Wit; Thomas J. T. P. van Den Berg; Katherine W. Kooij; Maria Prins; Reinier O. Schlingemann; Michael D. Abramoff; Peter Reiss; Frank D. Verbraak; on behalf of the AGEhIV Cohort Study Group
TAGS: cohort studies, hiv, hiv infections, contrast sensitivity
Invest. Ophthalmol. Vis. Sci.. 2016; 57(3):1388-1397. https://doi.org/10.1167/iovs.15-18537

Retina June 2015

Retinal Structure and Function in Perinatally HIV-Infected and cART-Treated Children: A Matched Case–Control Study

PDF

Nazli Demirkaya; Sophie Cohen; Ferdinand W. N. M. Wit; Michael D. Abramoff; Reinier O. Schlingemann; Taco W. Kuijpers; Peter Reiss; Dasja Pajkrt; Frank D. Verbraak
TAGS: child, hiv, retina, vision
Invest. Ophthalmol. Vis. Sci.. 2015; 56(6):3945-3954. https://doi.org/10.1167/iovs.15-16855

New Developments in Vision Research November 2014

The RD5000 Database: Facilitating Clinical, Genetic, and Therapeutic Studies on Inherited Retinal Diseases

PDF

Ramon A. C. van Huet; Clasien J. Oomen; Astrid S. Plomp; Maria M. van Genderen; B. Jeroen Klevering; Reinier O. Schlingemann; Caroline C. W. Klaver; L. Ingeborgh van den Born; Frans P. M. Cremers; the RD5000 Study Group
TAGS: genetics, retinal diseases
Invest. Ophthalmol. Vis. Sci.. 2014; 55(11):7355-7360. https://doi.org/10.1167/iovs.14-15317

Includes: Supplemental Content

1 2 3

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Differential Expression of Sex-Steroid Receptors in the Choroid Aligns With Central Serous Chorioretinopathy Sex Prevalence Across Different Ages

Correlation of Aqueous and Vitreous Protein Levels in Proliferative Diabetic Retinopathy and Their Association with Clinical Parameters

Shared pathophysiology in the neurovascular unit of the human retina and Alzheimer’s brain in type 2 diabetes

Identifying PLVAP-associated proteins involved in breakdown of the blood-retinal barrier in DME

Choroidal hyperpermeability patterns correlate with disease severity in central serous chorioretinopathy: CERTAIN study report 2.

Immunolocalization of sex-steroid receptors in the human eye tissue across ages: an implication for pregnancy-associated central serous chorioretinopathy

iPSC-derived blood vessel organoids to study pathological angiogenesis in ocular neovascular diseases

Cortisol-modulated Barrier Properties of Cultured Choroidal Endothelial Cells: a Model to Study Central Serous Chorioretinopathy

Safety and efficacy of fovea-involving half-dose photodynamic therapy for chronic central serous chorioretinopathy

Spontaneous resolution of subretinal fluid in chronic central serous chorioretinopathy: the Fuji sign

MicroRNA levels as a biomarker for anti-VEGF response in patients with diabetic macular edema

microRNA Expression Profile in the Vitreous of Proliferative Diabetic Retinopathy Patients and Differences from Patients Treated with Anti-VEGF Therapy

Comparing the efficacy of bevacizumab to ranibizumab in patients with diabetic macular edema: the BRDME study

Sodium iodate-induced retinal degeneration in small animal models for Age-related Macular degeneration

TNFα-Induced Disruption of the Blood–Retinal Barrier In Vitro Is Regulated by Intracellular 3′,5′-Cyclic Adenosine Monophosphate Levels

Association of Circulating Markers With Outcome Parameters in the Bevacizumab and Ranibizumab in Diabetic Macular Edema Trial

Type 2 diabetes mellitus patients with white dots in the central fundus and neuroretinal degeneration

HIV-Associated Neuroretinal Disorder in Patients With Well-Suppressed HIV-Infection: A Comparative Cohort Study

Retinal Structure and Function in Perinatally HIV-Infected and cART-Treated Children: A Matched Case–Control Study

The RD5000 Database: Facilitating Clinical, Genetic, and Therapeutic Studies on Inherited Retinal Diseases

To View More...

You must be signed into an individual account to use this feature.